Tomohiro Emura

932 total citations
11 papers, 783 citations indexed

About

Tomohiro Emura is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomohiro Emura has authored 11 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomohiro Emura's work include Colorectal Cancer Treatments and Studies (6 papers), Biochemical and Molecular Research (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Tomohiro Emura is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Biochemical and Molecular Research (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Tomohiro Emura collaborates with scholars based in Japan and Netherlands. Tomohiro Emura's co-authors include Masakazu Fukushima, Norihiko Suzuki, Hideyuki Ohshimo, Hideki Kazuno, Shingo Yano, Yukio Tada, Tetsuji Asao, Kenji Kitazato, Yuko Murakami and Fumio Nakagawa and has published in prestigious journals such as Biochemical Pharmacology, Bioorganic & Medicinal Chemistry and Cancer Science.

In The Last Decade

Tomohiro Emura

11 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomohiro Emura Japan	10	583	312	171	126	96	11	783
Daphne Voorn Netherlands	16	539 0.9×	389 1.2×	213 1.2×	90 0.7×	136 1.4×	21	911
Hiroyuki Okabe Japan	16	584 1.0×	243 0.8×	297 1.7×	145 1.2×	89 0.9×	37	850
C.J.A. van Moorsel Netherlands	14	644 1.1×	445 1.4×	333 1.9×	116 0.9×	141 1.5×	16	1.1k
Elisa Gallerani Switzerland	15	427 0.7×	308 1.0×	160 0.9×	71 0.6×	93 1.0×	42	773
A. Mathieu-Boué France	9	869 1.5×	522 1.7×	184 1.1×	204 1.6×	66 0.7×	14	1.1k
Yuji Shimamoto Japan	14	584 1.0×	346 1.1×	413 2.4×	50 0.4×	77 0.8×	19	947
Mitchell D. Nambu United States	3	286 0.5×	351 1.1×	271 1.6×	115 0.9×	76 0.8×	3	648
Y M Rustum United States	17	509 0.9×	435 1.4×	120 0.7×	78 0.6×	95 1.0×	29	900
Cassie M. Lane United States	14	334 0.6×	231 0.7×	148 0.9×	116 0.9×	93 1.0×	32	666
Yu Fukase Japan	7	944 1.6×	215 0.7×	265 1.5×	67 0.5×	283 2.9×	7	1.2k

Countries citing papers authored by Tomohiro Emura

Since Specialization

Citations

This map shows the geographic impact of Tomohiro Emura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohiro Emura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohiro Emura more than expected).

Fields of papers citing papers by Tomohiro Emura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohiro Emura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohiro Emura. The network helps show where Tomohiro Emura may publish in the future.

Co-authorship network of co-authors of Tomohiro Emura

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohiro Emura. A scholar is included among the top collaborators of Tomohiro Emura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohiro Emura. Tomohiro Emura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Tada, Yukio, Hideki Kazuno, Tsutomu Sato, et al.. (2017). Molecular modeling study of the thymidine phosphorylase inhibitor by SBDD and classical QSAR analysis. 17(0). 19–29. 1 indexed citations

Temmink, Olaf H., Tomohiro Emura, Michiel de Bruin, Masakazu Fukushima, & Godefridus J. Peters. (2007). Therapeutic potential of the dual‐targeted TAS‐102 formulation in the treatment of gastrointestinal malignancies. Cancer Science. 98(6). 779–789. 87 indexed citations

Emura, Tomohiro, Norihiko Suzuki, Akio Fujioka, Hideyuki Ohshimo, & Masakazu Fukushima. (2005). Potentiation of the antitumor activity of α, α, α-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo. International Journal of Oncology. 27(2). 449–55. 65 indexed citations

Emura, Tomohiro, Norihiko Suzuki, Masahiro Yamaguchi, Hideyuki Ohshimo, & Masakazu Fukushima. (2004). A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA. International Journal of Oncology. 25(3). 571–8. 96 indexed citations

Emura, Tomohiro, Fumio Nakagawa, Akio Fujioka, Hideyuki Ohshimo, & Kenji Kitazato. (2004). Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model. Oncology Reports. 11(2). 381–7. 18 indexed citations

Yano, Shingo, Hideki Kazuno, Tsutomu Sato, et al.. (2004). Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: Optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase. Bioorganic & Medicinal Chemistry. 12(13). 3443–3450. 48 indexed citations

Yano, Shingo, Hideki Kazuno, Norihiko Suzuki, et al.. (2004). Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: Discovery of novel orally active inhibitors of human thymidine phosphorylase. Bioorganic & Medicinal Chemistry. 12(13). 3431–3441. 28 indexed citations

Emura, Tomohiro, Yuko Murakami, Fumio Nakagawa, Masakazu Fukushima, & Kenji Kitazato. (2004). A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells. International Journal of Molecular Medicine. 13(4). 545–9. 87 indexed citations

Emura, Tomohiro, Fumio Nakagawa, Akio Fujioka, et al.. (2004). An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA. International Journal of Molecular Medicine. 13(2). 249–55. 71 indexed citations

10.

Fukushima, Masakazu, Norihiko Suzuki, Tomohiro Emura, et al.. (2000). Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2′-deoxyribonucleosides. Biochemical Pharmacology. 59(10). 1227–1236. 198 indexed citations

11.

Murakami, Yuko, Hideki Kazuno, Tomohiro Emura, et al.. (2000). Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells.. International Journal of Oncology. 17(2). 277–83. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact